Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Prodromal Alzheimer's Disease: early-phase trial registry
2 of 3 indexed Prodromal Alzheimer's Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Prodromal Alzheimer's Disease: 3 US clinical trials tracked, 2 recruiting.
Prodromal Alzheimer's Disease is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is AgeneBio, running 1 of these trials.
Enrollment posture brief
Registry condition prodromal-alzheimers-disease
OPEN 2 | RECR 67% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Prodromal Alzheimer's Disease lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Prodromal Alzheimer's Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Prodromal Alzheimer's Disease is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
AC Immune
NCT05462106
Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease
Emory University
NCT04029623
Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease
AgeneBio
NCT03486938
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Prodromal Alzheimer's Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Prodromal Alzheimer's Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Prodromal Alzheimer's Disease page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Prodromal Alzheimer's Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- AgeneBio sponsors the most Prodromal Alzheimer's Disease trials on record, review their full trial history before evaluating a specific study. See AgeneBio's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Prodromal Alzheimer's Disease condition card totals 3 registered trials; most-linked intervention AGB101 220 mg tablet; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.